General Dermatology

Alexandra P. Charrow, MD, FAAD, shares insights on the link between dermatology and irritable bowel disease at the AAD Annual Meeting.

Read more on how to navigate all the opportunities at this year’s AAD meeting, which starts today in Orlando, Florida.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

At AAAAI/WAO 2025, Bernstein explored new findings on rilzabrutinib and dupilumab in CSU, highlighting treatment gaps and future therapies.

The novel formulation improved the appearance of dry and chapped lips after 28 days of use.

Dematology Times' Editor in Chief interviews Adelaide Hebert, MD, who will be honored at the AAD 2025 Legacy Celebration for her impact on pediatric dermatology.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

Celebrate Women’s History Month 2025 with insights from leading female dermatologists and expert coverage from the AAD Annual Meeting in Orlando.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

Phase 3 trial results presented at AAAAI/WAO 2025 highlight dupilumab's efficacy in reducing itch severity and urticaria activity in CSU patients.

“It's so exciting to see all these incredible female talents behind me. I want to give back and I want to help them climb on my shoulders and go higher,” Haws said.

Explore the top headlines of the week including insights from Terri Philips, MD, FAAP, innovations in wound healing, and more.

Test your knowledge of key words and terms associated with dermatology news from the previous week.

In case you missed it, this week we had news about Arcutis’ sNDA for roflumilast in pediatric AD, the current clinical and aesthetic applications of snail mucin, positive results from the CHE delgocitinib trial in China, and more.

This week, we feature top articles from our sister publications on recent clinical trials, practice management, and innovative technology.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

Explore the top headlines of the month including the expanding role of NPs and PAs, a guide to 2025 conferences, and expert insights from Paul Friedman, MD.

Review our content from the month of February that recognizes patients and clinicians with skin of color.

Learn more about the in-depth topics covered in the February 2025 print issue of Dermatology Times.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

Dermatology Times is looking back on the top stories in dermatology from the month of February.

Dermatology Times is recapping our top expert interviews from the month of February.

Lead investigator Leon Kircik, MD, emphasized the need for collaboration between clinicians, technologists, and policymakers to maximize VR/AR’s potential.

This review of the latest dermatologic studies includes insights into

Catch up on dermatology news, highlights, and insights from the past 24 hours.

Researchers reported that propranolol initiation for infantile hemangiomas in pediatric patients is safe, with no significant complications, suggesting reduced need for intensive monitoring.

Catch up on dermatology news, highlights, and insights from the past 24 hours.

Explore the top headlines of the week including the expanding role of NPs and PAs, a clinician’s guide to chemical peels, and recently announced therapeutic updates.

Test your knowledge of key words and terms associated with dermatology news from the previous week.

In case you missed it, this week we had news about Arcutis’ new seborrheic dermatitis initiative with Odell Beckham Jr., Zabalafin’s IND for atopic dermatitis, dupilumab as a potential BP treatment, and more.